2026-09-22 Sale | 2026-09-24 4:29 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 148,079 | $1.6178 | $239,555 | 981,269 (Indirect) | View |
2026-09-16 Sale | 2026-09-18 6:37 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 33,892 | $1.91 | $64,734 | 986,885 (Indirect) | View |
2026-08-18 Sale | 2026-08-20 5:57 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 375,840 | $0.37333 | $140,313 | 7,850,155 (Indirect) | View |
2026-08-06 Sale | 2026-08-10 7:52 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 62,811 | $6.8751 | $431,829 | 3,877,094 (Indirect Direct) | View |
2026-07-30 Sale | 2026-08-03 5:32 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 116,474 | $6.9288 | $807,027 | 3,939,905 (Indirect Direct) | View |
2025-11-14 Sale | 2025-11-18 4:34 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 200,000 | $8.8 | $1,760,000 | 4,056,379 (Indirect Direct) | View |
2025-08-21 Sale | 2025-08-22 7:05 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 231,405 | $3.4595 | $800,549 | 8,224,699 (Indirect) | View |
2025-07-09 Sale | 2025-07-11 5:25 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 27,000 | $7.502 | $202,554 | 4,256,379 (Indirect Direct) | View |
2025-06-27 Sale | 2025-07-01 8:32 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 125,000 | $6.9331 | $866,633 | 4,283,379 (Indirect Direct) | View |
2024-09-11 Sale | 2024-09-13 6:54 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
2024-03-13 Purchase | 2024-03-15 4:15 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) | View |
2024-01-31 Purchase | 2024-02-02 4:32 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) | View |
2023-04-10 Sale | 2023-04-12 4:51 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 16,544,113 | $0.12 | $1,985,294 | 200,000 (Indirect) | View |
2023-03-07 Sale | 2023-03-09 4:35 pm | Rallybio Corp | RLYB | 5AM Partners V LLC Schwab Andrew J. 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 100,000 | $8.2 | $820,000 | 3,630,724 (Indirect) | View |
2022-11-11 Sale | 2022-11-15 8:32 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 105,281 | $2.7381 | $288,267 | 3,907,624 (Indirect) | View |
2022-10-31 Sale | 2022-11-02 7:49 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 54,209 | $2.7688 | $150,096 | 3,911,835 (Indirect) | View |
2022-10-06 Sale | 2022-10-11 7:10 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 600,000 | $4.1482 | $2,488,907 | 410,268 (Indirect) | View |
2022-09-14 Sale | 2022-09-16 6:03 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 558,168 | $1.8764 | $1,047,322 | 3,914,004 (Indirect) | View |
2022-09-06 Sale | 2022-09-08 8:01 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 770,000 | $2.0543 | $1,581,835 | 3,936,331 (Indirect) | View |
2022-09-06 Sale | 2022-09-08 7:58 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 226,622 | $4.8405 | $1,096,953 | 503,112 (Indirect) | View |
2022-08-16 Sale | 2022-08-18 8:05 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 400,000 | $1.6501 | $660,060 | 3,967,131 (Indirect) | View |
2022-06-03 Sale | 2022-06-07 5:02 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 150,000 | $12.5 | $1,875,000 | 2,478,969 (Indirect) | View |
2022-05-23 Sale | 2022-05-25 6:31 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 100,000 | $13 | $1,300,000 | 2,578,640 (Indirect) | View |
2022-04-11 Sale | 2022-04-13 4:51 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 270,000 | $5 | $1,350,000 | 537,301 (Indirect) | View |
2022-02-08 Sale | 2022-02-10 6:24 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 210,000 | $13.05 | $2,740,500 | 2,645,087 (Indirect) | View |
2021-11-02 Purchase | 2021-11-04 9:10 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) | View |
2021-11-01 Sale | 2021-11-03 4:38 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 295,000 | $13 | $3,835,000 | 333,144 (Indirect) | View |